Janus Henderson Group’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$298K Hold
3,100
﹤0.01% 2217
2025
Q4
$302K Hold
3,100
﹤0.01% 2206
2025
Q3
$221K Buy
+3,100
New +$207K ﹤0.01% 2307
2024
Q4
Sell
-24,207
Closed -$1.22M 2556
2024
Q3
$1.22M Sell
24,207
-2,698
-10% -$124K ﹤0.01% 1566
2024
Q2
$1.18M Buy
+26,905
New +$1.14M ﹤0.01% 1539
2024
Q1
Sell
-39,243
Closed -$1.86M 2554
2023
Q4
$1.86M Buy
39,243
+10,874
+38% +$457K ﹤0.01% 1293
2023
Q3
$1.26M Buy
28,369
+7,446
+36% +$346K ﹤0.01% 1437
2023
Q2
$999K Buy
20,923
+7,658
+58% +$345K ﹤0.01% 1614
2023
Q1
$522K Buy
+13,265
New +$482K ﹤0.01% 1989
2021
Q1
Sell
-13,196
Closed -$301K 1593
2020
Q4
$301K Buy
13,196
+713
+6% +$16.5K ﹤0.01% 1324
2020
Q3
$267K Buy
12,483
+1,977
+19% +$44.4K ﹤0.01% 1281
2020
Q2
$244K Buy
+10,506
New +$226K ﹤0.01% 1273

Other funds holding IRMD

Janus Henderson Group's IRMD Position: Q1 2026 in Review

Janus Henderson Group held its iRadimed (IRMD) position steady in Q1 2026 at 3,100 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

Janus Henderson Group first reported a position in IRMD in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.86M in Q4 2023. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Janus Henderson Group held 3,100 shares of iRadimed worth $298K as of Q1 2026.
  • Janus Henderson Group left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2217 holding.
  • Janus Henderson Group first reported a position in iRadimed in Q2 2020 and has held it in 12 quarters since.
  • Janus Henderson Group's iRadimed position peaked at $1.86M in Q4 2023.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.